Evaluation of the antiinflammatory activity of sodium valproate in rats and mice

General Pharmacology

Volumn 27, Issue 8, 1996, Pages 1395-1400

  Raza, Muhammad ^a   Dhariwal, Mohammad A H ^a   Ageel, Abdulrahman M ^a   Qureshi, Shoeb ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

antiinflammatory; granuloma; sodium valproate; thermoregulation

Indexed keywords

ANTICONVULSIVE AGENT; CARRAGEENAN; INDOMETACIN; SALICYLATE SODIUM; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; FEVER; GRANULOMA; HYPERTHERMIA; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PAW EDEMA; PRIORITY JOURNAL; RAT; RECTUM TEMPERATURE; THERMOREGULATION; YEAST;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BODY TEMPERATURE; BODY TEMPERATURE REGULATION; CARRAGEENAN; EDEMA; GRANULOMA; INDOMETHACIN; MALE; MICE; RATS; RATS, WISTAR; SODIUM SALICYLATE; VALPROIC ACID;

EID: 0030561504     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-3623(96)00073-0     Document Type: Article

References (45)

1. Anonymous, (1992) EPILIM®, Technical Brochure, UK.
2. Baillie T. A. (1992) Metabolism of valproate to hepatotoxic intermediates. Pharm. Weekbl. Sci. 14, 122-125.
3. Bartholini G. and Stadler H. (1977) Evidence for an intrastriatal GABAergic influence on dopamine neurons of cat. Neuropharmacology 16, 343-347.
4. Callaghan N., O'Hare J., O'Driscoll D., O'Neill B. and Daly M. (1982) Comparative study of exthosuximide and sodium valproate in the treatment of typical absence seizures (Petitimal). Dev. Med. Child. Neurol. 24, 830-836.
5. Campbell W. B. (1991) Lipid derived autocoids: Eicosanoids and platelet activation factors. In: The Pharmacological Basis of Therapeutics. (Edited by Gilman A. G., Rall T. W., Nies A. S. and Taylor P.) 8th ed. Pergamon Press, New York, pp. 600-617.
6. Chadwick D. (1988) Comparison of monotherapy with valproate and other antiepileptic drugs, in the treatment of seizure disorders. Am. J. Med. 84 (Suppl.1A), 3-6.
7. Chapman A., Keane P. E., Meldrum B. S., Simiand J. and Vernieres J. C. (1982) Mechanism of anticonvulsant action of valproate. Prog. Neurobiol. 19, 315-359.
8. Covanis A; Gupta A. K. and Jeavons P. M. (1982) Sodium valproate monotherapy and polytherapy. Epilepsia 23, 693-720.
9. Davidoff R. A. (1983) Studies of neurotransmitter actions (GABA, Glycin and convulsants): In: Epilepsy. (Edited by Ward A. A. Jr., Penry J. K. and Purpura D.) Raven Press, New York, pp. 53-83.
10. Davis R., Peter H., and McTavish D. (1994) Valproic acid: A reappraisal of its pharmacological properties and clinical efficacy in epilepsy. Drugs 47, 332-372.
11. De Feudis F. V. and Orensanz-Munoz L. M. (1980) Vertebrate GABA-Receptors; Involvement in CNS Functions and Behavior. In: Neurotransmitters, Receptors and Drug Action. (Edited by Essman W. B.) Spectrum, New York, pp. 143-178.
12. Di-Rosa, M., Giround, J. P. and Willoughby, D. A. (1971) Studies of the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine. J. Path. 104, 15-29.
13. Dreifuss F. E., Santilli N., Langer D. H., Sweeney K. P., Moline K. A. and Manander K. B. (1987) Valproic acid hepatic fatalities: a restrospective review. Neurology 37, 379-385.
14. Eastham R. D. and Jancar J. (1980) Sodium valproate and platelet counts. Bri Med. J. 280, 186.
15. Feriello R., and Smith M. C. (1989) Valproate, mechanism of action. In: Antiepileptic drugs. (Edited by Levy R., Mattson R., Meldrum B., Penry J. K. and Dreifuss F. E.) 3rd ed. Raven Press Ltd., New York, pp. 567-575.
16. Goldstein S., Shemano I., Demeo R. and Beiler J. M. (1967) Antiinflammatory activity of several irritants in three models of experimental inflammation in rats. Arch. Int. Pharmacodyn. 167, 39-53.
17. Hulsman J. (1989) Hyperammonaemia and the use of antiepileptic drugs, including valproate. In: Fourth International Symposium on Sodium Valproate and Epilepsy. (Edited by Chadwick D.) Royal Society of Medicine Services, London, pp. 163-168.
18. Insel P. A. (1991) Analgesic-antipyretic and antiinflammatory drugs; drugs employed in the treatment of rheumatoid arthritis and gout. In: The Pharmacological Basis of Therapeutics. (Edited by Gillman A. G., Rall T. W., Nies A. S. and Taylor P.) 8th ed. Pergamon Press, New York, pp. 638-681.
19. Jones M. T., Altaher A. R. H., Nicholson S. A., Branagan L. M., Campbel E. A. and Gillham B. (1983) Sodium valproate in the treatment of Nelson's syndrome. Symposium Suppl., Br J. Clin. Pract. 27, 142-149.
20. Koning S. T. A., Seimes H., Blacker F., Boenikle E., Groß-Selbeck G., Hanefeld F., Haas N., Kohler B., Koelfen W., Korinthenberg R., Kurek E., Lenard H.-G., Penin H-, Penzien J. M. Sehunke W., Schultz C., Stephani U., Stute M., Traus M., Weinmann H.-M. and Scheffiner D. (1994) Severe hepatotoxicity during valproate therapy: an update and report of eight new fatalities. Epilepsia 35, 1005-1015.
21. Krogsgaard-Larsen P. (1981) Gamma-Aminobutyric acid agonists, antagonists, and uptake inhibitors. Design and therapeutic aspects. J. Med. Chem. 24, 1377-1383.
22. Löscher W. (1985) Valproic acid (Antiepileptic drugs). In: Handbook of Experimental Pharmacology. (Edited by Frey H. H. and Janz D.) Vol. 74. Springer Verlag, Berlin, pp. 507-537.
23. Löscher W. and Vetter M. (1985) In vivo effects of aminooxyacetic acid and valproate on nerve terminals (synaptosomal) GABA levels in discrete brain areas of rats. Biochem. Pharmacol. 34, 1747-1756.
24. Loux J. J., Depalma P. D. and Yankell S. L. (1972) Antipyretic testing of aspirin in rats. Toxicol. Appl. Phamacol. 22, 672-675.
25. Murakami K., Sugimoto T., Nishida N., Woo M., Araki A., Kobayashi Y. and Sakane Y. (1990) Carnitine metabolism and morphometric change of liver mitochondria in valproate treated rats. Neuropediatrics 21, 187-190.
26. Nau H. and Löscher W. (1984) Valproic acid and metabolites: Pharmacological and toxicological studies. Epilepsia 25 (Suppl. 1), S14-S22.
27. Neophytides A. N., Nutt J. G. and Lodish J. R. (1979) Thrombocytopenia associated with sodium valproate treatment. Ann. Neurol. 5, 389-390.
28. Ohtani Y., Eudo F. and Matsudo J. (1982) Carnitine deficiency and hyperammonaemia associated with valproic acid therapy. J. Pediatr. 101, 782-785.
29. Ramsay R. E. (1984) Controlled and comparative trials with valproate: United States. Epilepsia 25 (Suppl.), S40-S43.
30. Redmond D. E. (1977) Alterations in the functions of nucleus locus coeruleus: A possible model for studies of anxiety. In: Animal Models of Psychiatry and Neurology. (Edited by Hanin I. and Usdin E.) Pergamon Press, Oxford, pp. 293-304.
31. Richardson S. G. N., Fletcher D. J., Jeavons P. M. and Stuart J. (1976) Sodium valproate and platelet function. Br. Med. J. 1, 221.
32. Sandler R. M., Bevan P. C. Roberts G. E. Emberson C., Voak D., Darnborough J. and Heeley A. F. (1979a) Interaction between sodium valproate and platelets: A further study. Br. Med. J. 2, 1476.
33. Sandler R. M., Emberson C., Roberts G. E., Voak D., Darnborough J. and Heeley A. F. (1979b) IgM platelet antibody due to sodium valproate. Br. Med. J. 2, 1683-1684.
34. Sato S., White B., Penry J. K., Dreifuss F. E., Sackellares J. C. and Kupferberg H. (1982) Valproic acid versus ethosuximide in the treatment of absence seizures. Neurology. 32, 153-163.
35. Schmidt D. (1982) Adverse Effects of Antiepileptic Drugs. Raven Press, New York.
36. Seng G. F., Benensohn J. and Bayer B. M. (1990) Changes in T and B lymphocyte proliferative responses in adjuvant-arthritic rats; antagonism by indomethacin. Eur. J. Pharmacol. 178, 267-273.
37. Sugimoto T., Araki A., Nishida N., Sakane Y., Woo M., Takeuchi T. and Kabayashi Y. (1987) Heatotoxicity in rats following administration of valproic acid: Effects of L-carnitine supplementation. Epilepsia 28, 373-377.
38. 1 L-carnitine on valaproate induced hyperammonaemia and hypoketonaemia in primary cultured hepatocytes. Biochem. Pharmacol. 37, 2255-2258.
39. Thurston J. H. and Hauhart R. E. (1992) Amelioration of adverse effects of valproic acid on ketogenesis and liver Co-enzyme A metabolism by co-treatment with pentothenate and carnitine in developing mice: possible clinical significance. Pediat. Res. 31, 419-423.
40. Turner R. A. (1965) Screening Methods in Pharmacology, pp. 1, 100 and 158, Academic Press, New York.
41. Van-Arman C. G. and Bahudar N. R. (1978) Antiarthritics. In: New Drugs: Discovery and Development. (Edited by Robin A. A.) Marcel Dekker Inc., New York, pp. 1-27.
42. Wilder B. J. and Ranjel R. J. (1988) Review of valproate monotherapy in the treatment of generalised tonic-clinic seizures. Am. J. Med. 84 (Suppl. 1A), 7-13.
43. Winter C. A., Risley E. A. and Nuss G. W. (1962) Carrageenan induced oedema in hind paw of the rats as an assay for antiinflammatory drugs. Proc. Soc. Exp. Biol. Med. 111, 544-547.
44. B receptor sites involved in rat thermoregulation. Gen. Pharmac. 19, 223-226.
45. A receptor sites in diazepam hypothermia. Gen. Pharmac. 20, 855-859.